ovulation suppression

Related by string. * ovulations . Ovulation : ovulation induction . induce ovulation . stimulate ovulation . stimulates ovulation . suppress ovulation . suppresses ovulation . preventing ovulation / suppressions . Suppression : wildfire suppression . ruthless suppression . bone marrow suppression . bloody suppression . Wildland Fire Suppression . brutal suppression . suppression * *

Related by context. Frequent words. (Click for all words.) 62 Estradiol 61 administered subcutaneously 60 goserelin 59 decitabine 59 gonadotropin 59 follicle stimulating hormone 58 serum concentrations 57 antitumor 57 alpha amylase 57 nelfinavir 56 progestogen 56 alpha blocker 56 virologic failure 56 valacyclovir 56 estradiol 56 mycophenolate mofetil 56 degarelix 56 luteal phase 56 epithelial ovarian cancer 55 IFN gamma 55 granisetron 55 PREZISTA r 55 calcitonin 55 intramuscularly 55 plasma concentrations 55 genotoxicity 55 dose regimens 54 GnRH 54 heavily pretreated 54 sustained virologic response 54 tipranavir 54 ZD# [001] 54 selegiline 54 luteinizing hormone 54 pharmacokinetic properties 54 viral suppression 54 antibody titers 54 prepubertal 54 pharmacodynamics 54 Laquinimod 54 nab paclitaxel 54 chlorambucil 54 pharmacokinetic profiles 54 oral bioavailability 54 Oestrogen 54 SCH # 53 neuroprotective properties 53 romidepsin 53 talabostat 53 seroconversion 53 ascending doses 53 antiangiogenic 53 plus dexamethasone 53 SRT# [003] 53 active comparator 53 antithrombotic 53 mg kg dose 53 NRTI 53 biodistribution 53 pharmacokinetic profile 53 adalimumab 53 elotuzumab 53 MIRCERA 53 optimal dosing 53 HER2 positive metastatic breast 53 serum uric acid 53 mitoxantrone 53 mcg dose 53 Progesterone 52 vicriviroc 52 estrogen hormone 52 peginterferon alfa 2b 52 #mg/kg [002] 52 intravesical 52 hormones estrogen 52 systemic toxicity 52 octreotide 52 Cmax 52 antiviral activity 52 virologic response 52 Secondary endpoints include 52 calcitriol 52 pazopanib 52 nilotinib 52 Amrubicin 52 glatiramer acetate 52 pharmacodynamic 52 CD4 + cell 52 lopinavir 52 #ME# 52 dose cohorts 52 Navelbine 52 rHuPH# 52 ascorbate 52 achieved statistical significance 51 amphotericin B 51 thromboembolic events 51 pharmacokinetic studies 51 administered orally 51 dosing regimens 51 antigen PSA

Back to home page